FPT Achieves 2024 EcoVadis Platinum Rating for Sustainability Through Its French Subsidiary
12.12.2024 08:24:00 CET | Business Wire | Press release
Global technology corporation FPT recently achieved the EcoVadis Platinum rating through its French subsidiary. This is the highest distinction in the survey conducted by EcoVadis, an international organization that evaluates corporate sustainability activities. The recognition places FPT in the top 1% of companies evaluated worldwide for their commitment to sustainable business practices.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211227891/en/
(Graphic: Business Wire)
The EcoVadis rating is a comprehensive assessment of a company’s environmental, social, and governance (ESG) practices. It includes a global network of over 130,000 companies of various sizes across 220+ industries and 180+ countries. Sustainability performance is assessed across 21 criteria in four themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
FPT attained an overall score of 88/100, with impressive ratings of 90/100 for both Labor & Human Rights and Ethics, and 80/100 for the Environment category. This achievement reflects the company’s commitment to all dimensions of environmental policies, efficient corporate governance protocols, robust employee professional development initiatives, and dedication to reducing carbon emissions.
Mdm. Chu Thi Thanh Ha, Chairwoman of FPT Software, FPT Corporation, said: “FPT’s recognition by EcoVadis comes as part of our broader sustainability strategy, which includes embracing technologies, cultivating future-ready talents and driving new values that will last generations. Moving forward, we will continue to prioritize sustainability across all levels of our operations, with ongoing initiatives and investments to integrate sustainable practices into our solutions and services, as well as the work we deliver to our global customers.”
In 2023, FPT received a Silver rating from EcoVadis, further demonstrating its dedication to sustainable and ethical practices. In 2024, the company achieved ISO 45001 certification, the international standard for occupational health and safety, across its twelve campuses and offices in Vietnam, Germany, and France. Additionally, FPT won the Job Creation Award at ESGBusiness Awards 2024 and joined the Pledge 1% movement, reinforcing its dedication to corporate social responsibility and community engagement.
Since entering France in 2008, FPT has solidified its market position and demonstrated its expertise by collaborating with global leaders such as Airbus, La Poste, Air Liquide, Quadient, etc. In 2023, the French subsidiary entered France's top 100 ICT Companies. That same year, the company further strengthened its capabilities by acquiring an 80% stake in French IT consulting firm AOSIS, enhancing its expertise in SAP, Data, Cloud, and smart solutions tailored for the aerospace, aviation, and transportation industries. Looking ahead, FPT aims to be among the Top 50 IT companies in France, targeting to expand its local workforce to over 500 experts and its presence in France and neighbouring Francophone countries.
About FPT
FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam. FPT operates in three core sectors: Technology, Telecommunications, and Education. During over three decades of development, FPT has constantly provided practical and effective products to millions of people and tens of thousands of business and non-business organizations worldwide, establishing Vietnam’s position on the global tech map. Keeping up with the latest market trends and emerging technologies, FPT has developed the Made-by-FPT ecosystem of services, products, solutions, and platforms, which enables sustainable growth for organizations and businesses and offers distinctive experiences to customers. In 2023, FPT recorded a total revenue of USD 2.17 billion and 48,000+ employees. For more information about global IT services, please visit https://fptsoftware.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20241211227891/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom